VERNOPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VERNOPHARMA
Largest movements
- Tangible fixed assets +€281,282
up €281,282 (+3,516%), from €8,000 to €289,282
of which Land and buildings: +€289,282
- Debts after one year +€248,524
new in 2025: €248,524
- Trade debts -€38,196
down €38,196 (-75.7%), from €50,479 to €12,283
- Other debts +€37,605
up €37,605 (+95.4%), from €39,412 to €77,017
- Tax, wage and social debts +€32,402
up €32,402 (+55.9%), from €57,928 to €90,330
of which Remuneration and social security: +€37,916
- Current portion of long-term debt +€10,109
up €10,109 (+740%), from €1,366 to €11,475
- Financial charges +€9,556
up €9,556 (+516%), from €1,851 to €11,407
- Depreciation +€9,073
up €9,073 (+212%), from €4,278 to €13,351
- Taxes -€4,215
down €4,215 (-95.1%), from €4,430 to €215
- Staff costs +€4,207
up €4,207 (+9.1%), from €46,070 to €50,277
- Other operating charges +€3,898
up €3,898 (+402%), from €970 to €4,868
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €281,954 | €568,206 | +€286,252 | +102% |
| Fixed assets | 21/28 | €8,000 | €289,282 | +€281,282 | +3,516% |
| Tangible fixed assets | 22/27 | €8,000 | €289,282 | +€281,282 | +3,516% |
| Land and buildings | 22 | - | €289,282 | +€289,282 | |
| Assets under construction and advance payments | 27 | €8,000 | - | -€8,000 | |
| Current assets | 29/58 | €273,954 | €278,924 | +€4,970 | +1.8% |
| Stocks and contracts in progress | 3 | €2,067 | €2,517 | +€450 | +21.8% |
| Stocks | 30/36 | €2,067 | €2,517 | +€450 | +21.8% |
| Amounts receivable within one year | 40/41 | €210,489 | €211,149 | +€660 | +0.3% |
| Trade receivables | 40 | €89,582 | €75,522 | -€14,060 | -15.7% |
| Other amounts receivable | 41 | €120,907 | €135,627 | +€14,720 | +12.2% |
| Current investments | 50/53 | €51,280 | €51,280 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €518 | €914 | +€396 | +76.4% |
| Deferred charges and accrued income | 490/1 | €9,600 | €13,064 | +€3,464 | +36.1% |
| Total equity and liabilities | 10/49 | €281,954 | €568,206 | +€286,252 | +102% |
| Equity | 10/15 | €128,832 | €122,490 | -€6,342 | -4.9% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €67,248 | €67,248 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,000 | €2,000 | = | 0.0% |
| Other | 1319 | €2,000 | €2,000 | = | 0.0% |
| Distributable reserves | 133 | €65,248 | €65,248 | = | 0.0% |
| Profit (loss) carried forward | 14 | €41,584 | €35,242 | -€6,342 | -15.3% |
| Amounts payable | 17/49 | €153,122 | €445,716 | +€292,594 | +191% |
| Amounts payable after more than one year | 17 | - | €248,524 | +€248,524 | |
| Financial debts | 170/4 | - | €248,524 | +€248,524 | |
| Amounts payable within one year | 42/48 | €149,185 | €191,105 | +€41,920 | +28.1% |
| Current portion of amounts payable after more than one year | 42 | €1,366 | €11,475 | +€10,109 | +740% |
| Trade debts | 44 | €50,479 | €12,283 | -€38,196 | -75.7% |
| Suppliers | 440/4 | €50,479 | €12,283 | -€38,196 | -75.7% |
| Taxes, remuneration and social security | 45 | €57,928 | €90,330 | +€32,402 | +55.9% |
| Taxes | 450/3 | €23,728 | €18,214 | -€5,514 | -23.2% |
| Remuneration and social security | 454/9 | €34,200 | €72,116 | +€37,916 | +111% |
| Other amounts payable | 47/48 | €39,412 | €77,017 | +€37,605 | +95.4% |
| Accrued charges and deferred income | 492/3 | €3,937 | €6,087 | +€2,150 | +54.6% |
| Remuneration, social security and pensions | 62 | €46,070 | €50,277 | +€4,207 | +9.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,278 | €13,351 | +€9,073 | +212% |
| Other operating charges | 640/8 | €970 | €4,868 | +€3,898 | +402% |
| Gross operating margin | 9900 | €68,306 | €70,177 | +€1,871 | +2.7% |
| Operating profit (loss) | 9901 | €16,988 | €1,681 | -€15,307 | -90.1% |
| Financial income | 75/76B | €2,646 | €3,599 | +€953 | +36.0% |
| Recurring financial income | 75 | €2,646 | €3,599 | +€953 | +36.0% |
| Financial charges | 65/66B | €1,851 | €11,407 | +€9,556 | +516% |
| Recurring financial charges | 65 | €1,851 | €11,407 | +€9,556 | +516% |
| Profit (loss) for the period before taxes | 9903 | €17,783 | -€6,127 | -€23,910 | |
| Income taxes | 67/77 | €4,430 | €215 | -€4,215 | -95.1% |
| Profit (loss) for the period | 9904 | €13,353 | -€6,342 | -€19,695 | |
| Profit (loss) for the period to be appropriated | 9905 | €13,353 | -€6,342 | -€19,695 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.